FILE PHOTO: Research Associate Parsa Parirokh, of RNA medicines company Arcturus Therapeutics, conducts research on a vaccine for the novel coronavirus (COVID-19) at a laboratory in San Diego, California, U.S., March 17, 2020. REUTERS/Bing Guan